Digital Trends & Insights: February 2026 – A pharmaphorum industry r... February's Trends Outside the Headlines, trends & insights report showed competitive advantage is increasingly shaped by delivery, not just discovery.
Sales & Marketing How war in the Middle East is disrupting medical supply chai... The impact of the geopolitical disruption is starting to tell on global supply chains for medicines and key chemicals for the pharmaceutical industry.
Digital Trends & Insights, January 2026: A pharmaphorum industry rep... Outside of the main headlines, our new Trends & Insights report looks at the wider breadth of life sciences industry news.
R&D No longer the little fish: How Europe is holding its own thr... It goes without saying that we are living in uncertain times, yet, this holds particularly true for the pharmaceutical industry.
Digital Digitalisation of pharma in 2025: What’s holding firms back? The ability to operate with real-time data, integrated systems, and validated automation is now essential.
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.